US Gov't Plans To Control COVID Vaccine Distribution At Least Through 2022; Already Authorized Products Have Booster Advantage

 
• By Sarah Karlin-Smith
  
David Kessler testifies at 11 May Senate HELP hearing on COVID-19
David Kessler, HHS Chief Science Officer for COVID, testifies 11 May at the Senate HELP Committee • Source: Screenshot

More from Vaccines

More from Pink Sheet